vs

Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and FRANKLIN WIRELESS CORP (FKWL). Click either name above to swap in a different company.

FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $11.9M, roughly 1.2× FRANKLIN WIRELESS CORP). FRANKLIN WIRELESS CORP runs the higher net margin — 4.5% vs -34.7%, a 39.2% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -33.1%). Over the past eight quarters, FRANKLIN WIRELESS CORP's revenue compounded faster (39.0% CAGR vs -26.3%).

Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.

Viaero Wireless is a regional wireless telecommunications company that provides direct coverage in Nebraska, eastern Colorado, western Kansas, and southeastern Wyoming. Based in Fort Morgan, Colorado, Viaero is often the primary cell tower owner in portions of its coverage area. Through roaming coverage partner relationships, Viaero customers can place and receive calls locally and across the country, internationally, and on cruise ships.

FENC vs FKWL — Head-to-Head

Bigger by revenue
FENC
FENC
1.2× larger
FENC
$13.8M
$11.9M
FKWL
Growing faster (revenue YoY)
FENC
FENC
+106.9% gap
FENC
73.8%
-33.1%
FKWL
Higher net margin
FKWL
FKWL
39.2% more per $
FKWL
4.5%
-34.7%
FENC
Faster 2-yr revenue CAGR
FKWL
FKWL
Annualised
FKWL
39.0%
-26.3%
FENC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FENC
FENC
FKWL
FKWL
Revenue
$13.8M
$11.9M
Net Profit
$-4.8M
$533.6K
Gross Margin
17.1%
Operating Margin
-18.5%
0.4%
Net Margin
-34.7%
4.5%
Revenue YoY
73.8%
-33.1%
Net Profit YoY
-141.1%
133.3%
EPS (diluted)
$-0.17
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FENC
FENC
FKWL
FKWL
Q4 25
$13.8M
$11.9M
Q3 25
$12.5M
$12.7M
Q2 25
$9.7M
$6.9M
Q1 25
$8.8M
$8.0M
Q4 24
$7.9M
$17.8M
Q3 24
$7.0M
$13.3M
Q2 24
$7.3M
$6.1M
Q1 24
$25.4M
$6.2M
Net Profit
FENC
FENC
FKWL
FKWL
Q4 25
$-4.8M
$533.6K
Q3 25
$-638.0K
$640.5K
Q2 25
$-3.2M
$-342.2K
Q1 25
$-1.2M
$-644.8K
Q4 24
$-2.0M
$228.7K
Q3 24
$-5.7M
$515.2K
Q2 24
$-5.6M
$-1.8M
Q1 24
$12.8M
$-1.2M
Gross Margin
FENC
FENC
FKWL
FKWL
Q4 25
17.1%
Q3 25
22.8%
Q2 25
18.0%
Q1 25
16.9%
Q4 24
18.2%
Q3 24
15.5%
Q2 24
10.5%
Q1 24
8.4%
Operating Margin
FENC
FENC
FKWL
FKWL
Q4 25
-18.5%
0.4%
Q3 25
-1.5%
4.6%
Q2 25
-28.3%
-19.0%
Q1 25
-9.2%
-24.6%
Q4 24
-11.8%
4.5%
Q3 24
-74.6%
-2.8%
Q2 24
-69.4%
-36.7%
Q1 24
54.2%
-25.2%
Net Margin
FENC
FENC
FKWL
FKWL
Q4 25
-34.7%
4.5%
Q3 25
-5.1%
5.0%
Q2 25
-32.7%
-4.9%
Q1 25
-13.3%
-8.1%
Q4 24
-25.0%
1.3%
Q3 24
-82.2%
3.9%
Q2 24
-76.5%
-28.9%
Q1 24
50.6%
-19.0%
EPS (diluted)
FENC
FENC
FKWL
FKWL
Q4 25
$-0.17
$0.05
Q3 25
$-0.02
$0.05
Q2 25
$-0.11
$-0.03
Q1 25
$-0.04
$-0.05
Q4 24
$-0.02
$0.02
Q3 24
$-0.21
$0.04
Q2 24
$-0.20
$-0.16
Q1 24
$0.41
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FENC
FENC
FKWL
FKWL
Cash + ST InvestmentsLiquidity on hand
$36.8M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.5M
$35.1M
Total Assets
$70.6M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FENC
FENC
FKWL
FKWL
Q4 25
$36.8M
$24.3M
Q3 25
$21.9M
$25.3M
Q2 25
$18.7M
$25.9M
Q1 25
$22.7M
$25.3M
Q4 24
$26.6M
$21.9M
Q3 24
$40.3M
$40.7M
Q2 24
$43.1M
$37.5M
Q1 24
$51.2M
$31.7M
Total Debt
FENC
FENC
FKWL
FKWL
Q4 25
Q3 25
$19.4M
Q2 25
$19.4M
Q1 25
$19.4M
Q4 24
$19.3M
Q3 24
$32.1M
Q2 24
$31.8M
Q1 24
$31.3M
Stockholders' Equity
FENC
FENC
FKWL
FKWL
Q4 25
$35.5M
$35.1M
Q3 25
$-4.5M
$35.1M
Q2 25
$-7.5M
$34.5M
Q1 25
$-5.9M
$35.3M
Q4 24
$-5.9M
$36.0M
Q3 24
$-5.2M
$35.8M
Q2 24
$-1.4M
$35.1M
Q1 24
$3.0M
$36.9M
Total Assets
FENC
FENC
FKWL
FKWL
Q4 25
$70.6M
$53.0M
Q3 25
$49.3M
$53.3M
Q2 25
$44.9M
$51.3M
Q1 25
$46.4M
$49.7M
Q4 24
$44.9M
$54.5M
Q3 24
$58.9M
$51.6M
Q2 24
$63.2M
$46.7M
Q1 24
$69.2M
$50.0M
Debt / Equity
FENC
FENC
FKWL
FKWL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
10.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FENC
FENC
FKWL
FKWL
Operating Cash FlowLast quarter
$-6.0M
$-4.1M
Free Cash FlowOCF − Capex
$-4.1M
FCF MarginFCF / Revenue
-34.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-7.66×
TTM Free Cash FlowTrailing 4 quarters
$-9.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FENC
FENC
FKWL
FKWL
Q4 25
$-6.0M
$-4.1M
Q3 25
$1.5M
$-1.5M
Q2 25
$-3.7M
$2.3M
Q1 25
$-4.3M
$-5.9M
Q4 24
$-1.5M
$2.7M
Q3 24
$-2.2M
$2.7M
Q2 24
$-8.4M
$6.2M
Q1 24
$39.0M
$-779.0K
Free Cash Flow
FENC
FENC
FKWL
FKWL
Q4 25
$-4.1M
Q3 25
$-1.5M
Q2 25
$2.3M
Q1 25
$-5.9M
Q4 24
$2.7M
Q3 24
$2.6M
Q2 24
$6.2M
Q1 24
$-816.0K
FCF Margin
FENC
FENC
FKWL
FKWL
Q4 25
-34.3%
Q3 25
-11.7%
Q2 25
33.6%
Q1 25
-73.7%
Q4 24
15.4%
Q3 24
19.9%
Q2 24
101.3%
Q1 24
-13.2%
Capex Intensity
FENC
FENC
FKWL
FKWL
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.6%
Cash Conversion
FENC
FENC
FKWL
FKWL
Q4 25
-7.66×
Q3 25
-2.32×
Q2 25
Q1 25
Q4 24
11.99×
Q3 24
5.18×
Q2 24
Q1 24
3.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons